Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
rhBNP for end-stage heart failure (single-arm, open-label, phase 4)
ChiCTR2600128287Phase 4Recruiting
- Sponsor
- Shanghai Tenth People's Hospital
- Start
- Jul 2026
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of nesiritide in heart failure (HF), sponsored by Shanghai Tenth People's Hospital. Primary endpoint: New York Heart Association (NYHA) functional class at day 90. Started Jul 2026; status: recruiting.
02
Drugs
nesiritide
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on ChiCTR2600128287.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600128287.